OpenVSafe by OpenVAERS
Search V-safe

XXA-32411-89641

3 vaccinations 14 coded responses 27 check-ins 14 free-text entries 6 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
852 / AZ
Registered
2021-02-20
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-18
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-20
    Registered in v-safe
  3. 2021-02-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  4. 2021-02-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  5. 2021-02-22
    Survey response — days 1–6 daily, dose 1
    MedDRA: Axillary pain, Lymph node pain, Sinus congestion — Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  6. 2021-02-27
    Health check-in — 7 day, dose 1
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  7. 2021-03-05
    Survey response — 14 day, dose 1
    MedDRA: Rash — Feeling: Good
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  8. 2021-03-11
    Dose 2 — Pfizer-BioNTech
  9. 2021-03-11
    Survey response — 0 day, dose 2
    MedDRA: Throat irritation — Feeling: Fair · Site: Pain, Itching · Fever · Headache, Fatigue or tiredness, Abdominal pain · Be unable to work
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  10. 2021-03-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Muscle spasms — Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  11. 2021-03-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  12. 2021-03-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Muscle or body aches
    Adult check-in
  13. 2021-03-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Impaired healing, Skin disorder — Feeling: Good · Rash, not including the immediate area around the injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  14. 2021-03-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-03-18
    Health check-in — 7 day, dose 2
    Feeling: Fair · Fatigue or tiredness, Diarrhea
    Adult check-in
  16. 2021-03-25
    Survey response — 14 day, dose 2
    MedDRA: Office visit, Pre-existing disease, Skin infection — Feeling: Fair · Get care from a doctor or other healthcare professional
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  17. 2021-03-25
    Report sent to call center — 14 day, dose 2
    Get care from a doctor or other healthcare professional
    no matching call case
  18. 2021-04-03
    Survey response — 21 day, dose 2
    MedDRA: Unevaluable event — Feeling: Fair
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  19. 2021-04-15
    Survey response — 35 day, dose 2
    MedDRA: Adverse drug reaction, Condition aggravated, Impaired healing, Office visit, Pre-existing disease, Staphylococcal infection — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  20. 2021-04-15
    Report sent to call center — 35 day, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  21. 2021-04-24
    Survey response — 42 day, dose 2
    MedDRA: Chills, Nausea, Pyrexia, Vomiting — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  22. 2021-04-24
    Report sent to call center — 42 day, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  23. 2021-06-10
    Survey response — 3 month, dose 2
    MedDRA: Skin infection — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  24. 2021-06-10
    Report sent to call center — 3 month, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-06-18
  26. 2021-09-12
    Health check-in — 6 month, dose 2
    Feeling: Fair
    Adult check-in
  27. 2022-03-11
    Dose 3 — Pfizer-BioNTech
  28. 2022-03-14
    Survey response — 12 month, dose 2
    MedDRA: Injection site swelling, Mobility decreased, Pain — Feeling: Fair · Be unable to work or attend school
    MedDRA releases: 2024-11 · check-in answers available
  29. 2022-03-15
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Redness · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  30. 2022-03-16
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  31. 2022-03-17
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  32. 2022-03-18
    Health check-in — 7 day, dose 3
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  33. 2022-03-26
    Survey response — 14 day, dose 3
    MedDRA: Intermenstrual bleeding, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional
    MedDRA releases: 2024-11 · check-in answers available
  34. 2022-03-26
    Report sent to call center — 14 day, dose 3
    Get care from a doctor or other healthcare professional
    1 call case(s)
  35. 2022-03-28
  36. 2022-04-06
    Survey response — 21 day, dose 3
    MedDRA: Heavy menstrual bleeding, Unevaluable event, Vaginal haemorrhage — Feeling: Poor · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11 · check-in answers available
  37. 2022-04-06
    Report sent to call center — 21 day, dose 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  38. 2022-04-12
  39. 2022-06-10
    Survey response — 3 month, dose 3
    MedDRA: COVID-19, Fine motor skill dysfunction — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    MedDRA releases: 2024-11 · check-in answers available
  40. 2022-06-10
    Report sent to call center — 3 month, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  41. 2022-06-13
  42. 2022-06-13
  43. 2022-06-13
  44. 2022-06-13
  45. 2022-06-13
  46. 2022-06-13
  47. 2022-09-12
    Health check-in — 6 month, dose 3
    Feeling: Poor
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-02-18Pfizer-BioNTech
22021-03-11Pfizer-BioNTech
32022-03-11Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-04-15 Unsuccessful
2021-04-24 Unsuccessful
2021-06-10 Unsuccessful
2022-03-26 Unsuccessful
2022-04-06 Unsuccessful
2022-06-10 Unsuccessful

1 report(s) with no call case — see the timeline.

Free text

Release 4

Systemic reaction (other): Underarm hurts where my lymphnodes are, severe. Sinus congestion

Release 5

Symptoms: I have a rash on my underarm on same arm as vaccine. Started 4 days ago

Systemic reaction (other): Scratchy throat

Systemic reaction (other): Horrible muscle spasms in my calves lasting over 30 min

Systemic reaction (other): My body. Hasnt been able to heal with skin issues as it used to.

Release 6

Symptoms: I already have really sensitive skin and always get skin infections that usually clear up right away. But not since I took the first dose. Like my body wont fight the infections as it normally would. I have to take doxycycline now treat it.
Healthcare visit (other): Dermalogist

Symptoms: Skin

Release 7

Symptoms: Somehow caught MRSA not having the ability to heal . Antiobiotics are making me sicker
Healthcare visit (other): In person visit

Symptoms: Nausea fever chills, vomiting

Release 9

Symptoms: Skin infections not healing

Release 11

Symptoms: The booster made my body ache all over and my injection was swollen. I couldnt move my arm for a day.

Symptoms: Spotting after period
Healthcare visit (other): Going to dr appt this monday.

Symptoms: Still spotting and now period is heavier.
Healthcare visit (other): I have a dr appt on 4/7/22

Release 12

Symptoms: Loss of some fine motor skills due to recent covid infection

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
HCVOUnevaluable event · · ✓
SDAdverse drug reaction · · ✓
SDChills ✓ ✓ ✓
SDCondition aggravated ✓ ✓ ○
SDCOVID-19 · · ✓
SDFine motor skill dysfunction · · ✓
SDHeavy menstrual bleeding · · ✓
SDImpaired healing · · ✓
SDInjection site swelling · · ✓
SDIntermenstrual bleeding · · ✓
SDMobility decreased · · ✓
SDNausea ✓ ✓ ✓
SDPain · · ✓
SDPre-existing disease ✓ ✓ ✓
SDPyrexia ✓ ✓ ✓
SDRash ✓ ✓ ✓
SDSkin infection ✓ ✓ ✓
SDStaphylococcal infection ✓ ✓ ✓
SDUnevaluable event ✓ ✓ ✓
SDVaginal haemorrhage · · ✓
SDVomiting ✓ ✓ ✓
SROAxillary pain ✓ ✓ ✓
SROImpaired healing ✓ ✓ ✓
SROLymph node pain ✓ ✓ ✓
SROMuscle spasms ✓ ✓ ✓
SROSinus congestion ✓ ✓ ✓
SROSkin disorder ✓ ✓ ✓
SROThroat irritation ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release